immunitoAI
AI-driven antibody design for therapeutic development.
immunitoAI’s platform generates novel antibody sequences optimized for target binding, specificity, and developability. Researchers specify disease targets and receive candidate molecules in silico, accelerating lead discovery and reducing lab screening time.
Related
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA for cell modulation.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.
Adbrain
Adbrain
Cross-device identity for personalized marketing.
Cofounder
Cofounder
Aerska
Aerska
Developing RNA medicines to treat, delay, and prevent diseases of the brain.
Cofounder
Founded
2025